Value Bridge — SWEDISH MEDICAL CENTER CHERRY HILL
Current $-70M → Target $-59M (+$10.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-69.7M
Current EBITDA
$-59.4M
Target EBITDA
+$10.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.3M
Payer Mix Optimization
$5.6M
Cost to Collect Reduction
$1.9M
Clean Claim Improvement
$1.4M
Volume & Rate Growth
$9.3M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-70M to $-59M. The highest-impact lever is Volume & Rate Growth at $3.7M probability-weighted.
IC talking point: "We see $10M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $113M in equity value creation."